Drugmaker Lundbeck beats Q4 sales expectations, eyes return to growth in 2020

Danish drugmaker Lundbeck posted fourth quarter sales slightly above expectations on Thursday, helped by a stronger performance from key drugs, and said it expected to return to sales growth in 2020.